Study of ENMD-2076 in Patients With Multiple Myeloma

Clinical trial NCT00806065 · COMPLETED

Trial details

NCT number: NCT00806065
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-12-01
Primary completion: 2011-11-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.